Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1980 3
1981 3
1982 4
1983 5
1984 6
1985 5
1986 7
1987 2
1988 11
1989 8
1990 6
1991 10
1992 1
1993 8
1994 5
1995 9
1996 5
1997 8
1998 6
1999 9
2000 8
2001 9
2002 7
2003 9
2004 9
2005 8
2006 3
2007 10
2008 10
2009 2
2010 10
2011 10
2012 8
2013 12
2014 9
2015 10
2016 11
2017 5
2018 11
2019 7
2020 10
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Results by year
Filters applied: . Clear all
Page 1
Nemorubicin.
Broggini M. Broggini M. Top Curr Chem. 2008;283:191-206. doi: 10.1007/128_2007_6. Top Curr Chem. 2008. PMID: 23605633
RAS/RAF/MEK inhibitors in oncology.
Rusconi P, Caiola E, Broggini M. Rusconi P, et al. Among authors: broggini m. Curr Med Chem. 2012;19(8):1164-76. doi: 10.2174/092986712799320510. Curr Med Chem. 2012. PMID: 22257058 Review.
KRAS Targeting and Resistance: Anticipating the Expectable.
Colombo M, Ndembe G, Broggini M. Colombo M, et al. Among authors: broggini m. J Thorac Oncol. 2021 Aug;16(8):1239-1241. doi: 10.1016/j.jtho.2021.05.002. J Thorac Oncol. 2021. PMID: 34304850 No abstract available.
Platinum Resistance in Ovarian Cancer: Role of DNA Repair.
Damia G, Broggini M. Damia G, et al. Among authors: broggini m. Cancers (Basel). 2019 Jan 20;11(1):119. doi: 10.3390/cancers11010119. Cancers (Basel). 2019. PMID: 30669514 Free PMC article. Review.
PI3K/AKT/mTOR inhibitors in ovarian cancer.
Mazzoletti M, Broggini M. Mazzoletti M, et al. Among authors: broggini m. Curr Med Chem. 2010;17(36):4433-47. doi: 10.2174/092986710794182999. Curr Med Chem. 2010. PMID: 21062259 Review.
p73: a chiaroscuro gene in cancer.
Marabese M, Vikhanskaya F, Broggini M. Marabese M, et al. Among authors: broggini m. Eur J Cancer. 2007 Jun;43(9):1361-72. doi: 10.1016/j.ejca.2007.01.042. Epub 2007 Apr 10. Eur J Cancer. 2007. PMID: 17428654 Review.
LKB1ness Dictates ERK Inhibitors Response in NSCLC.
Caiola E, Broggini M, Marabese M. Caiola E, et al. Among authors: broggini m. J Thorac Oncol. 2020 Apr;15(4):e59. doi: 10.1016/j.jtho.2020.02.006. J Thorac Oncol. 2020. PMID: 32216950 Free article. No abstract available.
291 results